LDN-57444 100mg 100mg | Purity Not Available
Adooq Bioscience
LDN-57444 is a potent, reversible, competitive and active site-directed inhibitor of UCHL1.
More Information Supplier PageLDN-57444 is a potent, reversible, competitive and active site-directed inhibitor of UCHL1.
More Information Supplier PageLDN-57444 is a potent, reversible, competitive and active site-directed inhibitor of UCHL1.
More Information Supplier PageJNJ7777120 is a potent, selective non-imidazole H4?histamine receptor antagonist.
More Information Supplier PageJNJ7777120 is a potent, selective non-imidazole H4?histamine receptor antagonist.
More Information Supplier PageJNJ7777120 is a potent, selective non-imidazole H4?histamine receptor antagonist.
More Information Supplier PageJNJ7777120 is a potent, selective non-imidazole H4?histamine receptor antagonist.
More Information Supplier PageJNJ7777120 is a potent, selective non-imidazole H4?histamine receptor antagonist.
More Information Supplier PageEPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. It induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells.
More Information Supplier PageLDN-57444 is a potent, reversible, competitive and active site-directed inhibitor of UCHL1.
More Information Supplier PageLDN-57444 is a potent, reversible, competitive and active site-directed inhibitor of UCHL1.
More Information Supplier Page